Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNET
1401
DELISTED
RigNet, Inc.
RNET
| $1.34M | ﹤0.01% |
24,851
+7,300
| +42% | +$366K |
|
1402
Installed Building Products
IBP
$6.55B
| $1.34M | ﹤0.01% |
+109,064
| New | +$1.45M |
|
1403
Pacira BioSciences
PCRX
$993M
| $1.33M | ﹤0.01% |
14,501
-2,400
| -14% | -$183K |
|
1404
PetMed Express
PETS
$38.2M
| $1.33M | ﹤0.01% |
98,800
-158,529
| -62% | -$2.09M |
|
|
CJES
1405
DELISTED
C&J ENERGY SVCS LTD
CJES
| $1.33M | ﹤0.01% |
+39,400
| New | +$1.21M |
|
|
AXDX
1406
DELISTED
Accelerate Diagnostics
AXDX
| $1.32M | ﹤0.01% |
5,084
+1,530
| +43% | +$334K |
|
|
BTU
1407
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $1.32M | ﹤0.01% |
5,373
-10,967
| -67% | -$2.85M |
|
|
HGG
1408
DELISTED
hhgregg Inc.
HGG
| $1.31M | ﹤0.01% |
128,828
-250,703
| -66% | -$2.3M |
|
1409
Invesco Municipal Trust
VKQ
$538M
| $1.31M | ﹤0.01% |
104,549
+2,828
| +3% | +$34.9K |
|
1410
Teledyne Technologies
TDY
$29B
| $1.31M | ﹤0.01% |
13,465
| – | – |
|
1411
John Wiley & Sons Class A
WLY
$2.69B
| $1.3M | ﹤0.01% |
21,500
+10,700
| +99% | +$608K |
|
|
USG
1412
DELISTED
Usg
USG
| $1.3M | ﹤0.01% |
43,209
+600
| +1% | +$18.4K |
|
|
KSU
1413
DELISTED
Kansas City Southern
KSU
| $1.3M | ﹤0.01% |
12,100
-12,300
| -50% | -$1.27M |
|
|
JGV
1414
DELISTED
NUVEEN GLOBAL EQUITY INCOME FUND
JGV
| $1.3M | ﹤0.01% |
+88,265
| New | +$1.23M |
|
1415
EnerSys
ENS
$6.87B
| $1.29M | ﹤0.01% |
18,751
+5,400
| +40% | +$367K |
|
|
MPT
1416
Medical Properties Trust
MPT
$2.48B
| $1.29M | ﹤0.01% |
97,360
+2,200
| +2% | +$29.2K |
|
|
HPP
1417
Hudson Pacific Properties
HPP
$803M
| $1.29M | ﹤0.01% |
+7,257
| New | +$1.21M |
|
1418
Equity Lifestyle Properties
ELS
$12.7B
| $1.29M | ﹤0.01% |
58,248
+13,800
| +31% | +$295K |
|
|
CUB
1419
DELISTED
Cubic Corporation
CUB
| $1.28M | ﹤0.01% |
28,827
-4,720
| -14% | -$225K |
|
|
ACET
1420
DELISTED
Aceto Corp
ACET
| $1.28M | ﹤0.01% |
70,710
+23,800
| +51% | +$458K |
|
1421
Cirrus Logic
CRUS
$5.57B
| $1.28M | ﹤0.01% |
56,338
-1,757
| -3% | -$38.5K |
|
1422
Future Fuel
FF
$239M
| $1.28M | ﹤0.01% |
77,141
-43,000
| -36% | -$781K |
|
1423
MillerKnoll
MLKN
$1.57B
| $1.28M | ﹤0.01% |
42,315
-2,900
| -6% | -$89.8K |
|
1424
Spire
SR
$4.92B
| $1.28M | ﹤0.01% |
26,371
-41,200
| -61% | -$1.93M |
|
|
PDCE
1425
DELISTED
PDC Energy, Inc.
PDCE
| $1.28M | ﹤0.01% |
20,269
+6,100
| +43% | +$383K |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.